Loading
Latest filing published 01 Apr 2025 for GeoVax Labs, Inc., €10k.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David A. Dodd is a declared insider at 3 companies; the most frequent names are GeoVax Labs, Inc., Medizone International Inc and Serologicals Corp. The record holds 23 filings, for trades running from 15 March 2006 to 1 April 2025.
Purchases make up the whole of the open-market record (18 purchases, €533k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. 2025 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €9,617. Clusters matter here: 5 out of 6 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
On 1 April 2025 came the latest disclosure, an open-market purchase for €10k in GeoVax Labs, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations